Health Story Tracker

Investigations by the CDC and public health officials establish that the multistate Cyclospora outbreak has grown to affect 15 states, with at least 98 hospitalizations alongside the two deaths in Michigan.

Michigan health officials and the CDC report two deaths in Michigan linked to the outbreak involving individuals with significant underlying health conditions.

Building upon the foundational understanding of GPR15's role in inflammatory bowel disease, ongoing research is actively driving the development of new diagnostic tools and targeted therapies. These efforts are specifically aimed at restoring proper GPR15 signaling pathways or enhancing the migration of protective immune cells to combat the disease. This current phase of research seeks to translate earlier findings into practical clinical applications for IBD patients.

A study published in July 2026 indicates that aldesleukin, a treatment targeting the immune system, shows promise in preventing repeat heart attacks. In an early-stage clinical trial, none of the participants who received aldesleukin experienced further heart attacks two years post-treatment, compared to 11% in the placebo group. The treatment works by reducing inflammation in major blood vessels.

A University of Glasgow study, part of the TARTAN-HF trial, has demonstrated that a simple blood test can identify undiagnosed heart failure in a significant number of individuals with diabetes. The research found that nearly a quarter of participants in the screening arm received a new heart failure diagnosis within six months. This highlights the need for targeted screening programs for this demographic.

As of July 2026, UCLA researchers, including Varghese John, Istvan Mody, and S. Thomas Carmichael, are actively engaged in the final preparations for human clinical trials for DDL-920. While the Investigational New Drug (IND) application is being finalized or is under review, no trials have officially commenced. The team is focused on securing regulatory approval and initiating Phase 1 studies for this promising molecule.

The national MenB vaccination campaign has been expanded to include 17-18 year olds and those starting university for the first time, with over 130,000 appointments booked in the first week of July 2026. The Joint Committee on Vaccination and Immunisation (JCVI) has also provided recommendations to the government regarding a routine MenB adolescent vaccination program. This expansion follows a meningitis outbreak at the University of Kent in March 2026.

The NHS in North East England is urging young people to get vaccinated against Meningitis B due to ongoing risks. This follows earlier outbreaks in Kent and Berkshire in early 2026 that resulted in fatalities and hospitalizations.

New firearms licensing fees are scheduled to be implemented on June 4, 2026, following ongoing discussions and implemented changes to UK gun license laws. A preliminary hearing was also held regarding the Secretary of State for Justice and others, concerning these ongoing legal and legislative developments.

Zen Principle Naturals has voluntarily recalled its Moringa Leaf Powder Capsules due to potential Salmonella contamination. As of July 22, 2026, 131 people have been reported ill across 38 states, with illness onset dates ranging from August 2025 to June 2026.

Federal officials are investigating multiple moringa supplement manufacturers, including Why Not Natural and Dr's Pride, due to systemic supply chain issues and an expanding multistate Salmonella outbreak. The CDC confirmed contamination has spread to additional products, suggesting the raw moringa ingredient itself may be contaminated before reaching supplement producers.

Ongoing studies are evaluating ketamine's efficacy in reducing fatigue among cancer survivors and individuals with chronic illnesses like chronic fatigue syndrome and lupus. Research suggests ketamine can reduce tiredness within 40 minutes, with effects lasting up to 14 days. A Phase II clinical trial is also assessing intravenous low-dose ketamine for fatigue associated with multiple sclerosis (MS).

Researchers at Kanazawa University have developed a new blood gene test that detects 90% of early-stage pancreatic cancers. Northwestern University has developed a test detecting KRAS mutations in over 90% of pancreatic cancers, with over 55% detection even when CT scans are clear. ClearNote Health's Avantect test showed 82.6% overall sensitivity in a high-risk cohort.

An experimental drug, daraxonrasib, has demonstrated significant survival gains in clinical trials for metastatic pancreatic cancer, leading to a standing ovation at the ASCO 2026 conference. Spanish researchers achieved complete tumor regression in mice using a triple-combination therapy targeting the KRAS signaling pathway.

The UAE has initiated a public consultation process to establish regulations for xenotransplantation and 3D bioprinted tissues. This move aims to address safety, ethics, and future applications in response to the global organ shortage.

Thailand has approved zoliflodacin (Nuzolvence) on July 27, 2026, for the treatment of uncomplicated urogenital gonorrhea, making it the second country to do so after the U.S. FDA's approval. The World Health Organization (WHO) is also developing recommendations for the use of new oral antibiotics like zoliflodacin.

The U.S. FDA approved two new antibiotics, zoliflodacin (Nuzolvence) and gepotidacin (Bluejepa), for the treatment of gonorrhea. These approvals, occurring on December 11 and 12, 2025, mark the first new treatments for the infection in two decades and offer options against drug-resistant strains. The World Health Organization is developing recommendations for these new oral antibiotics.

KJ Muldoon, the first infant treated with personalized CRISPR gene-editing therapy for a rare metabolic disorder, has shown significant improvement, tolerating increased dietary protein and requiring less medication. Separately, Daniel Cressy in the Gulf South region has been functionally cured of Sickle Cell Disease after receiving Casgevy, a CRISPR/Cas9 gene therapy.

Steven Mills and Tiffany Score have reached a custody agreement with the biological parents of their daughter, Shea, who was born due to an embryo mix-up at the Fertility Center of Orlando. The agreement, reached in April 2026, grants Mills and Score permanent legal custody of Shea. An embryo linked to the biological parents is undergoing testing, and the couple has secured a new facility for future fertility treatments and embryo storage.

The biological parents of the child have been identified as of April 2026, though their identities are being kept confidential. The couple suing the Fertility Center of Orlando will continue to parent the child, while the lawsuit remains open to address questions about their own embryos. The clinic is scheduled to close on May 20, 2026.

Actor Quinton Aaron has been discharged from the hospital and is now undergoing intensive physical therapy following a spinal stroke and cyst diagnosis. He was hospitalized in January 2026 and placed on life support.

The New York State Nurses Association (NYSNA) reached a tentative agreement with Catholic Health/St. Charles Hospital on July 8, 2026, averting a strike scheduled for July 13. The agreement, ratified on July 10, includes improved safe staffing standards, new workplace violence protections, and annual base wage increases of 4%, 3%, and 4% over a three-year contract.

Nurses at NewYork-Presbyterian have rejected a tentative agreement and remain on strike as of July 3, 2026. This follows tentative deals reached with Mount Sinai and Montefiore, which could allow nearly 11,000 nurses to return to work. The strike, involving 15,000 nurses advocating for safe staffing ratios, began on January 12, 2026.

As of July 6, 2026, four infants were hospitalized with botulism linked to Nara Organics Whole Milk Organic Powdered Infant Formula, with illnesses occurring between April and May 2026. The FDA is urging manufacturers to improve supplier oversight following this and a previous outbreak linked to ByHeart formula.

Savannah Guthrie returned to the 'Today' show anchor desk on April 6, 2026, after nearly three months away, with her absence also attributed to her mother's abduction from their home on February 1, 2026. Her mother remains missing, and the family has offered a $1 million reward for information leading to her safe return.

Savannah Guthrie revealed that before her vocal cord surgery, she initially tried to embrace her raspier voice, comparing it to 'sexy Demi Moore,' but ultimately 'couldn't ignore it anymore,' leading to her decision for the procedure.

For the week ending May 23, 2026, New York City's emergency department visits for respiratory illnesses showed a slight decrease, with flu cases remaining stable at 0.25% of ED visits. This data follows a period of record-breaking flu hospitalizations in late 2025.